NCT04881955View on ClinicalTrials.gov

Study of the Absorption, Metabolism, and Excretion of [14C]-Ecopipam in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

May 12, 2021

Primary Completion Date

September 7, 2021

Study Completion Date

September 7, 2021

Conditions
Healthy Volunteer
Interventions
DRUG

[14C]-Ecopipam

\[14C\]-Ecopipam

Trial Locations (1)

LS2 9LH

Covance Clinical Research Unit Ltd., Leeds

Sponsors

Collaborators (1)

Covance
All Listed Sponsors
collaborator

Covance

INDUSTRY

lead

Emalex Biosciences Inc.

INDUSTRY